Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.
about
Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional studyBiophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemiaConcentration of intracellular hepatic apolipoprotein E in Golgi apparatus saccular distensions and endosomesThe Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.STAT1 interacts with RXRα to upregulate ApoCII gene expression in macrophages.Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4Novel changes in discoidal high density lipoprotein morphology: a molecular dynamics study.The apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people.Genetic risk factors for perinatal arterial ischemic strokeThe carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.Opposite regulation of the human apolipoprotein M gene by hepatocyte nuclear factor 1 and Jun transcription factors.Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.Two regulatory elements of similar structure and placed in tandem account for the repressive activity of the first intron of the human apolipoprotein A-II gene.Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors.Identification of immunogenic proteins of the cysticercoid of Hymenolepis diminuta.Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia.
P2860
Q25257069-E0F3282C-71DF-4E44-B245-33A313EC433EQ28477741-FBFFB2B9-B61A-41DF-8B25-844DE705DA96Q28571083-38E03E7C-A1AA-4FE6-91FE-2680CBE39504Q30248596-74794ACF-A1C2-4D8F-9A68-586FB297780BQ33825134-F2C92577-BB3C-44A5-87AB-F44A6D5041FFQ34125571-DE64BCFE-1C2F-40B3-B74A-01000DBB94F8Q34342038-0ABF1829-621E-447E-A04F-63F1EA895AE4Q34395148-395240B5-C1B2-41F2-9610-AADF2426C811Q34646862-AFBC2908-F9B5-4E87-BFCB-E144557A8CBFQ35844221-9F6B2F7E-2FA4-4282-B118-C9260DC431D4Q36515111-73309681-F32E-416B-B998-C5CC60FE2F8AQ36859049-EBAA244F-CACF-419B-ACAD-53C9DC5214C9Q38357712-AFF00DF6-4823-4B13-90BF-9C1336E2D433Q39567068-BA2E5DE8-36A1-4182-8875-05FB00C2C678Q40132293-74B276F1-F52C-4D15-BF7A-A285F6BA0989Q41172042-816E01D2-C3C5-451D-8931-1EE8AB2DC8D1Q42049578-76AD9EC7-28FF-4AF2-9796-12BAD32AA769Q46257822-A796E1BA-F70B-4CC0-998A-CCA6F6799677Q51064399-9075F6EF-298A-44C2-893D-FA7B5964CBA4
P2860
Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.
@en
type
label
Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.
@en
prefLabel
Genetic mutations affecting human lipoproteins, their receptors, and their enzymes.
@en
P2093
P1476
Genetic mutations affecting human lipoproteins, their receptors, and their enzymes
@en
P2093
P304
P577
1993-01-01T00:00:00Z